MX359887B - Composicion masticable para administracion oral y proceso para preparar la misma. - Google Patents

Composicion masticable para administracion oral y proceso para preparar la misma.

Info

Publication number
MX359887B
MX359887B MX2015010486A MX2015010486A MX359887B MX 359887 B MX359887 B MX 359887B MX 2015010486 A MX2015010486 A MX 2015010486A MX 2015010486 A MX2015010486 A MX 2015010486A MX 359887 B MX359887 B MX 359887B
Authority
MX
Mexico
Prior art keywords
composition
oral administration
massable
prepare
same
Prior art date
Application number
MX2015010486A
Other languages
English (en)
Other versions
MX2015010486A (es
Inventor
Renouard Marie
Daste Georges
Derouet Benjamin
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2015010486A publication Critical patent/MX2015010486A/es
Publication of MX359887B publication Critical patent/MX359887B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231—Pectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Confectionery (AREA)

Abstract

La presente invención se refiere a composiciones masticables para administración oral, comprendiendo dichas composiciones pectina de alto contenido en metilo, glicerol y agua. Ventajosamente, la composición masticable puede comprender un fármaco. La presente invención también se refiere a un proceso para preparar la composición masticable y al uso de dicha composición masticable como un medicamento.
MX2015010486A 2013-02-14 2014-02-12 Composicion masticable para administracion oral y proceso para preparar la misma. MX359887B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13305172 2013-02-14
PCT/EP2014/052746 WO2014124981A1 (en) 2013-02-14 2014-02-12 Chewable composition for oral administration and process for preparing thereof

Publications (2)

Publication Number Publication Date
MX2015010486A MX2015010486A (es) 2015-10-26
MX359887B true MX359887B (es) 2018-10-15

Family

ID=47739180

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015010486A MX359887B (es) 2013-02-14 2014-02-12 Composicion masticable para administracion oral y proceso para preparar la misma.

Country Status (17)

Country Link
US (1) US9474713B2 (es)
EP (1) EP2956011B1 (es)
JP (1) JP6346623B2 (es)
KR (1) KR20150116861A (es)
CN (1) CN105007750A (es)
AR (1) AR094770A1 (es)
AU (1) AU2014217965B2 (es)
BR (1) BR112015018200B1 (es)
CA (1) CA2900597C (es)
HU (1) HUE038489T2 (es)
IL (1) IL239958A (es)
MX (1) MX359887B (es)
PL (1) PL2956011T3 (es)
RU (1) RU2015138710A (es)
SG (1) SG11201505541VA (es)
TW (1) TWI622408B (es)
WO (1) WO2014124981A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2083304C (en) 1991-12-31 1999-01-26 Stephen R. Huszar Equalization and decoding for digital communication channel
FR2999937B1 (fr) 2012-12-21 2015-01-09 Sanofi Sa Unite solide a haute teneur en fexofenadine et son procede de preparation
WO2018175261A1 (en) * 2017-03-20 2018-09-27 Bayer Healthcare Llc Chewable gel products for active pharmaceutical ingredients
DE102017107845A1 (de) * 2017-04-11 2018-10-11 Gelita Ag Gelatineprodukt mit einer Kernkomponente und Verfahren zu dessen Herstellung
BR112020008653A2 (pt) * 2017-11-02 2020-10-27 Zambon S.P.A. composições farmacêuticas compreendendo safinamida
EP3549579A1 (en) 2018-04-03 2019-10-09 Sanofi Winthrop Industrie Oral gum formulation and fabrication process thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723348B2 (en) 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US20080274196A1 (en) 2005-08-05 2008-11-06 Lipin Limited Oral Pharmaceutical Suspension Compositions Of Fexofenadine
US9155772B2 (en) 2008-12-08 2015-10-13 Philip Morris Usa Inc. Soft, chewable and orally dissolvable and/or disintegrable products
CN101628117B (zh) * 2009-08-18 2011-02-16 北京航洋胶囊技术有限公司 一种咀嚼软胶囊皮、咀嚼软胶囊药物及其制备方法
BR112012014558B8 (pt) * 2009-12-16 2021-05-25 Shasun Pharmaceuticals Ltd nova composição de hidrogel transdérmico de dexibuprofeno
US20120251484A1 (en) * 2011-03-31 2012-10-04 Cp Kelco Aps Cold prepared gel and method for making same
KR101303479B1 (ko) * 2011-07-28 2013-09-06 (주)씨엘팜 가식성 필름형성 조성물 및 약물이 함유된 가식성 필름형 제제
FR2999937B1 (fr) 2012-12-21 2015-01-09 Sanofi Sa Unite solide a haute teneur en fexofenadine et son procede de preparation

Also Published As

Publication number Publication date
EP2956011A1 (en) 2015-12-23
MX2015010486A (es) 2015-10-26
IL239958A (en) 2017-11-30
RU2015138710A (ru) 2017-03-20
CA2900597A1 (en) 2014-08-21
AU2014217965B2 (en) 2017-03-23
TW201440821A (zh) 2014-11-01
AR094770A1 (es) 2015-08-26
US20150374622A1 (en) 2015-12-31
WO2014124981A1 (en) 2014-08-21
HUE038489T2 (hu) 2018-10-29
KR20150116861A (ko) 2015-10-16
TWI622408B (zh) 2018-05-01
JP2016507579A (ja) 2016-03-10
AU2014217965A1 (en) 2015-08-20
PL2956011T3 (pl) 2018-09-28
EP2956011B1 (en) 2018-03-28
CA2900597C (en) 2021-11-02
BR112015018200A2 (pt) 2017-07-18
BR112015018200B1 (pt) 2020-11-03
CN105007750A (zh) 2015-10-28
JP6346623B2 (ja) 2018-06-20
US9474713B2 (en) 2016-10-25
SG11201505541VA (en) 2015-08-28
IL239958A0 (en) 2015-08-31

Similar Documents

Publication Publication Date Title
CY1123953T1 (el) Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
BR112014007134A2 (pt) usos de um composto da fórmula (b), compostos, composição farmacêutica, método de preparação do composto e uso de uma quantidade efetiva de um composto
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
IL239022B (en) Tetracycline topical formulations, preparation and uses thereof
MX388946B (es) Esteroides neuroactivos sustituidos con 19-alcoxi-17, profarmacos de los mismos, y metodos de tratamiento usando los mismos.
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
BR112015018087A8 (pt) composto, composição farmacêutica e uso
BR112014003802A2 (pt) composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento
BR112015031979A2 (pt) letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir.
UY35704A (es) Compuestos y composiciones como inhibidores de la mek
NI201200157A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
UY34356A (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
MX2015012833A (es) Composiciones antibioticas de ceftolozano.
BR112015025814A2 (pt) composição farmacêutica para uso inalatório, processo para a preparação de uma composição farmacêutica, composição sólida para uso como um diluente de pós para inalação e kit para a administração de um fármaco como pó para inalação
UA116889C2 (uk) Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc)
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
DOP2016000007A (es) Pirazolpiridinas sustituidas
BR112015031417A8 (pt) forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem
UY35848A (es) Tienopirimidinas
BR112016001876A2 (pt) composto de benzoxaborol tricíclico, método de preparação e uso do mesmo
MX2016001422A (es) Composicion farmaceutica de fingolimod.
EA201400444A1 (ru) Производные 2-оксопиперидинила
BR112016005361B8 (pt) Composto, composição, e, uso de um composto
BR112013025610A2 (pt) uso de um metapneumovírus aviário vivo, e, composição farmacêutica

Legal Events

Date Code Title Description
FG Grant or registration